Final Exam Drugs and Behavior

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/85

encourage image

There's no tags or description

Looks like no tags are added yet.

86 Terms

1
New cards

hallucinogens

  • class of drugs that produce distortions in perception and alterations in one’s sense of reality

  • chemically similar to: serotonin, norepinephrine, or acetylcholine

  • classifications:

    • serotonin-related

    • norepinephrine-related

    • acetylcholine-related

    • dissociate anesthetics


2
New cards

hallucinogenic

hallucination producing

3
New cards

psychedelic

mind-expanding

4
New cards

pscyhomimetic

having the appearance of psychosis

5
New cards

plant hallucinogens

  • Psilocybin

  • DMT

  • Mescaline

  • Atropine

  • Scopolamine


6
New cards

synthetic hallucinogens

  • LSD

  • DOM

  • MDMA

  • PCP

  • ketamine


7
New cards

lyseric acid deithlamide

  • synthetic hallucinogenic drug that alters a person’s perception of reality and of themselves

    • ergot (found in moldy rye/grains)

    • lyseric acid (found in ergot→ precursor)


8
New cards

ergot

a fungus found in moldy rye and grains

9
New cards

lysergic acid

highly toxic compound found in ergot; precursor for LSD

10
New cards

LSD history

  • discovered on accident (1943), Albert Hoffman, a Swiss research chemist was testing new chemical and got trace amounts on fingers

  • 1953: pharmaceutical company wanted to use for schizophrenia research [would just be used for symptom therapy] (resembles symptoms)

  • MKUltra (1953-1973)

    • was one of the most heavily experimented drugs with MKUltra

    • CIA gave people high doses without telling them

      • prisoners, mental patients, drugs addicts, etc.

      • director bought entire supply from labs ($4 billion)

    • tested whether Soviet spies defect against their will if given

  • 1961: Alpert and Leary

    • Harvard researchers studying hallucinogens

      • gave this and psilocybin to students

      • started having session at home and off-campus and got fired

  • 1966- became illegal (state-level)

  • 1970: schedule 1 substance under controlled substances act (federal)


11
New cards

LSD acute effects

  • doses are extremely potent

    • typical dose: 5-150 micrograms

  • oral administration

    • effects felt within 30-60 minutes

    • blood levels peak around 2 hours

    • half life of ~3 hours

  • very low toxicity: margin of safety 300-600 (one death has ever been reported)


12
New cards

phases of LSD effects

  1. initial effects (30 minutes-2 hours)

  2. psychedelic trip (6-12 hours)

  3. comedown (4-6)


13
New cards

LSD initial effects

  • 1st phase of LSD effects

  • 30 minutes to 2 hours

    • sympathetic arousal (increased HR, BP, and dilated pupils)

    • restlessness, euphoria, release of tension, heightened emotions


14
New cards

psychedelic trip

  • 2nd phase of LSD effects

    • 4 main features:

      • images seen with eyes closed

      • synesthesia (mixing of senses, sounds as visions)

      • perception of a multilevel reality

      • strange and exaggerated configurations of common objects or experiences

    • good trips vs bad trips are highly variable (what are your expectations, setting you are in, pre-existing conditions


15
New cards

comedown

  • 3rd phase of LSD effects

    • 4-6 hours after

    • intense mood swings or panic, loss of perception of time, separation between mind and body


16
New cards

LSD on the brain

  • stimulates 5-HT2a receptors (serotonin)

    • special subtype of serotonin receptor associated with hallucinogenic effects

      • 5-HT1a linked to depression and anxiety

      • 5-HT2a linked to schizophrenia and psychosis


17
New cards

facts about LSD

  • does not produce dependence

  • sometimes produces panic attacks but leads to no long-term psychiatric problems/psychosis

  • does not increase creativity

  • does not damage chromosomes

  • potentially has some long-term residual effects, but unsure (flashbacks)

  • does not increase violent behavior directly (can make you more impulsive)


18
New cards

serotonin-related hallucinogens

  • psilocybin

  • DMT


19
New cards

psilocybin

  • a serotonin-related hallucinogen drug that originates from a species of mushroom (magic mushrooms)

    • used as far back as 500 BC

    • at small doses (4-5mg) causes relaxation

    • at larger doses (15mg+) causes hallucinations and time distortions

  • mimics and triggers the release of serotonin


20
New cards

psilocybin vs LSD

  • less potent (larger doses needed)

  • shorter trips (4-6 hours total)

  • more visual effects, less emotionally intense

  • decreased risk of paranoia


21
New cards

depression and treatment-resistant depression

  • granted “breakthrough therapy” status by FDA in 2018

  • patient goes on psilocybin trip in a safe, controlled environment while therapist asks questions

  • followed up with talk therapy


22
New cards

psilocybin in psychotherapy

  • PTSD/Trauma

    • decreases overall symptoms of trauma

    • creates safer environment for talking about trauma

  • Anxiety and end-of-life anxiety

    • generally decreases anxiety symptoms

    • enhances spiritual wellbeing

  • substance abuse

    • alcohol and tobacco

    • best when combined with psychotherapy

    • promotes neuroplasticity

      • breaks up rigid thought patterns


23
New cards

dimethyltryptamine

  • short acting hallucinogenic drug taken from the bark of trees nativeto Central and South America

    • “The businessman’s LSD”

    • similar to LSD but with way shorter effects

    • most effects over in an hour


24
New cards

norepinephrine-related hallucinogens

  • mescaline

  • MDMA


25
New cards

mescaline

  • hallucinogenic drug derived from the peyote cactus

    • acts very similarly to LSD (in the sense of adrenaline)

    • used in religious ceremonies in the Native American church


26
New cards

MDMA

  • synthetic hallucinogenic drug that has both stimulant and hallucinogenic properties

    • schedule 1 substance

    • acts similarly to methamphetamine

    • “Rave” drug

  • acute effects:

    • increased HR, BP, BT, euphoria, heightened senses, decreased inhibition

    • toxic effects - hyperthermia, cardiovascular effects

  • chronic effects:

    • cognitive impairments, emotional difficulties, confusion, anxiety, impulsive control, sleep problems, attention and memory deficits


27
New cards

MDMA potential therapeutic application

  • PTSD

    • severe symptoms

    • comorbid with other disorders

    • special populations (i.e. veterans)

  • Recent studies:

    • 67% remission for MDMA + therapy

      • vs 32% for placebo

    • 71% remission for MDMA + therapy vs 48% for placebo (2023)

      • vs 48% for placebo (2023)


28
New cards

acetylcholine-related hallucinogens

  • amanita muscaria (fly agaric)

  • anticholinergic drugs

    • atropine

    • scopolamine


29
New cards

amanita muscaria

  • hallucinogenic drug derived from a species of mushroom containing the hallucinogen ibotenic acid, which increase the activity of acetylcholine

    • historically, taken by vikings before battle to give them energy

    • can be dangerous and result in twitching, spasms, dizziness, and aggression


30
New cards

anticholinergic drugs

  • drugs that block the parasympathetic effects of acetylcholine (acetylcholine-blocking drugs)

    • ex: Atropine

    • ex: scopolamine


31
New cards

atropine

  • anticholinergic hallucinogenic drug derived from the nightshade plant, used to stabilize heart rate

    • highly lethal

  • effects: accelerated heart rate, increased blood pressure, reduced saliva/mucus, possible lightheadedness


32
New cards

scopolamine

  • anticholinergic hallucinogen drug derived from themandrake plant, used to treat nausea and motion sickness

    • effects: reduced saliva/mucus production, relaxation of smooth muscles in stomach


33
New cards

dissociative anesthetics

  • class of drug that causes an out of body trance-like state associated with pain relief, sedation, and amnesia

    • use usually results in either partial or total amnesia

    • alters glutamate activity (increases a low doses, decreases at high doses)

    • ex: PCP and ketamine (and salvia)


34
New cards

salvia divinorium

  • type of dissociative anesthetic

    • intense and short acting


35
New cards

phencyclidine

  • a dissociative anesthetic hallucinogen that produces disorientation, agitation, aggression, analgesia, and amnesia

    • has stimulant, depressant, and analgesic properties

    • difficult to regulate, unpredictable effects

    • schedule 2 substance

  • effects:

    • mania, depression, severe anxiety, prolonged stares, sudden mood changes, confusion, paranoia, and unpredictable aggression

      • makes people able to withstand considerable amounts of pain

      • hallucinations specifically about one’s own body

      • partial or total amnesia

        • deaths from suicides, accidental/intentional mutilations, drownings, falls, etc.


36
New cards

ketamine

  • a dissociative anesthetic hallucinogen used primarily as an anesthetic for medical procedures

    • schedule 3 substance

    • acts very similarly to PCP

  • effects:

    • pain relief, increased pain tolerance, sedation, trance-like state

    • partial or total amnesia

  • therapeutic application

    • effective for treatment-resistant depression

    • works faster than traditional antidepressants


37
New cards

mental illness in US

  • more than 1 in 5 U.S adults experience

  • 1 in 20 adults have serve mental illnesses

  • more than 1 in 7 youth have mental health disorder


38
New cards

biomedical model

  • the perspective that abnormal thoughts and behaviors associated with mental illness are the results of abnormal biochemical processes in the brain

    • by altering these processes (using drugs) we can address these symptoms


39
New cards

psychiatric drugs

  • a type of medication used to treat some form of mental illness


40
New cards

antipsychotic drugs

  • drugs intended to treat the symptoms of schizophrenia

    • block D2 receptors (dopaminergic receptors)


41
New cards

schizophrenia

  • severe mental disorder that involves abnormal perceptions of reality; extremely high heritability, occurs in ~1% of the population

  • symptoms (positive/additive):

    • hallucinations- visual/auditory stimuli that aren’t really there

    • delusions- beliefs about oneself or events that aren’t rooted in reality

    • paranoia- from disordered thinking, can be fear of attacks

    • disorientations- confusion about present time/place


42
New cards

psychotic history

  • mid 1950’s- around 50% of hospitalized patients were psychiatric patients

    • majority were for schizophrenia (overdiagnosed)

    • barbiturates, lobotomies common

  • number of mental hospital patients decreased 80% over the next 30 years

    • 1955- introduction of antipsychotic drugs (cut the number of schizophrenia patients in half)

    • psychiatric patients only admitted to mental hospitals for limited periods of time (deinstitutionalization)


43
New cards

first generation antipsychotics

  • typical

    • developed in the 1950’s

    • ex: chlorpromzine (thorazine), haloperidol (haldol)

  • significant reduction of hallucinations and delusions

  • doesn’t affect less severe symptoms (apathy, disorientations)

  • resulted in Parkinson-like symptoms (tarditive dyskinesia, stiff walk, slow movement, loss of coordination)

  • FULLY BLOCK D2 RECEPTORS—-PARKINSON’S LIKE SYMPTOMS


44
New cards

second generation antipsychotics

  • atypical

    • developed in 1980’s

    • ex: clozapine (clozaril), risperodone (risperdal), quetiapine (seroquel)

  • significant reduction of hallucinations and delusions AND less severe symtpoms and NO Parkinson-like symptoms

  • potential for weight gain, hyperglycemia, diabetes, heart problems, blood disease

  • PARTIALLY BLOCK D2 RECEPTORS (and some serotonin receptors)

    • serotonin decreases dopamine production


45
New cards

third-generation antipsychotics

  • new atypical

    • developed in 2000’s

    • ex: aripiprazol (ablify), lumateperone (caplyta)

  • significant reduction of hallucinations and delusions AND less severe symptoms AND no Parkinson's-like symptoms AND no weight gain or diabetes risk

  • MODULATES D2 RECEPTORS—only in specific neural pathways

    • only blocks those in neural pathways with elevated dopamine activity


46
New cards

antidepressant drugs

drugs intended to treat the symptoms of depression

  • First developed in 1950’s—-discovered on accident, improved mood was a “side effect” of TB treatment

  • depression is so different from person to person, not one type is the “best”


47
New cards

depression

  • the most common mood disorder; symptoms include persistent sadness, loss of interest in activities, low energy

    • around 1 in 5 people will meet criteria during their lifetime


48
New cards

First generation antidepressants

  • 1950’s

  • include:

    • monoamine oxidase inhibitors

    • tricyclic antidepressants

  • no longer widely prescribed due to adverse side effects


49
New cards

monoamine oxidase inhibitors

  • type of first generation (MAOIs)

  • antidepressants that prevent the breakdown of serotonin, dopamine, and norepinephrine

    • ex: Phenelzine (Nardil), Tranylcypromine (Parnate)

    • extremely strict dietary restrictions

  • present in liver, breaks down tyramine

  • excess tyramine increases stroke risk and BP


50
New cards

tricyclic antidepressants

  • type of first generation (TCA)

  • antidepressants that prevent the reuptake of serotonin and norepinephrine

    • ex: Nortriptylin (Pamelor), Imipramine (Tofranil)

  • no dietary restrictions, can cause dizziness, dry mouth, HR issues, etc.


51
New cards

second generation antidepressants

  • type of antidepressants created in 1980

  • include:

    • selective serotonin reuptake inhibitors (SSRI)

    • Serotonin antagonist and reuptake inhibitors (SARI)

  • most common first-line choice for treatment


52
New cards

selective serotonin reuptake inhibitors

  • type of second generation antidepressant

    • antidepressants that prevent the reuptake of serotonin

    • ex: Escitalopram (Lexapro), Fluoxetine (Prozac), Setraline (Zoloft)

  • fewer physiological side effects than first gen


53
New cards

serotonin antagonist and reuptake inhibitors

  • type of second generation antidepressant

    • antidepressants that prevent the reuptake of serotonin and inhibit a protein that typically inhibits serotonin production

    • ex: Trazodone (Desyrel), Nefazodone (Serzone)

  • not widely prescribed for depression, sometimes used for insomnia and panic attacks


54
New cards

third generation antidepresants

  • type of antidepressant made in 1990

  • includes: serotonin-norepinephrine reuptake inhibitors (SNRI)

  • Most recently developed; good alternatives to SSRI


55
New cards

serotonin-norepinephrine reuptake inhibitors

  • type of 3rd generation antidepressant

    • type of antidepressant that prevents the reuptake of serotonin and norepinephrine

      • ex: Duloxetine (Cymbalta(, Venlafaxine (Effexor)

    • similar mechanism as tricyclics, but with larger margin of safety and fewer rise effects


56
New cards

off-label usage

  • the use of psychiatric medications for purposes other than what they are specified for

    • psychiatric disorders may overlap in neurological pathways

      • drugs can treat multiple disorders

        • ex: SSRI for anxiety disorders


57
New cards

mood stabilizers

  • medications used to treat the symptoms of bipolar disorder by reducing the severity of both manic and depressive symptoms


58
New cards

bipolar disorder

  • disorder characterized by intense mood swings between mania and depression

  • off label approaches; second gen (atypical) antipsychotics

    • ex: Risperodone (Risperdal) and Quetiapine (Seroquel)


59
New cards

lithium carbonate

gold standard treatment for bipolar disorder; levels out strong mood swings


60
New cards

Autism Spectrum Disorder

  • developmental disability that impairs social functioning and produces repetitive patterns of behavior

    • off label approaches: second gen and third gen antipsychotics

      • ex: Risperodone (Risperdal) and Aripiprazole (Abilify)


61
New cards

Obsessive Compulsive disorder

  • mental health condition characterized by uncontrollable recurring thoughts (obsessions) and behaviors (compulsions)

    • off label approaches: SSRI

      • fluoxetine (Prozac), Sertraline (Zoloft), etc.


62
New cards

deinstitutionalization history

  • prior to 1960’s- main approach to treating severely impaired psychiatric patients is institutionalization at large mental hospitals

  • 1960’s- supreme court decides that involuntary admission to large psychiatric hospitals would only be allowed if there were no other feasible means of treatment with more freedom


63
New cards

deinstitutionalization

  • social policy that involves encouraging the treatment of individuals with mental illness in a community-based program rather than a large mental hospital

    • good at first, many mental health centers did not live up to expectations

      • 1/3 of the homeless population have depression, bipolar disorder, or schizophrenia

      • around 350,000 individuals who are in jail or prison have depression, bipolar disorder, or schizophrenia


64
New cards

substance abuse prevention objectives

  1. establishing constructive lifestyles and norms that discourage substance abuse

  2. establishing social and physical environments that facilitate a drug-free lifestyle


65
New cards

supply-side approaches

  • reduce the supply of drugs in our soiety

    • law enforcement, drug trafficking control

    • led by DEA


66
New cards
67
New cards
68
New cards
69
New cards
70
New cards
71
New cards
72
New cards
73
New cards
74
New cards
75
New cards
76
New cards
77
New cards
78
New cards
79
New cards
80
New cards
81
New cards
82
New cards
83
New cards
84
New cards
85
New cards
86
New cards